Psoriasis and type 2 diabetes risk among psoriatic patients in a Spanish population

Australasian Journal of Dermatology

Volumn 53, Issue 2, 2012, Pages 128-130

  Armesto, Susana ^a   Santos Juanes, Jorge ^b   Galache Osuna, Cristina ^b   Martinez Camblor, Pablo ^b   Coto, Eliecer ^b   Coto Segura, Pablo ^b  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

diabetes mellitus; psoriasis

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; HOSPITAL; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; PSORIASIS; PSORIATIC ARTHRITIS; RISK FACTOR; SMOKING; SPAIN;

ADULT; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PREVALENCE; PSORIASIS; RISK FACTORS; SMOKING; SPAIN;

EID: 84861094522     PISSN: 00048380     EISSN: 14400960     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2011.00802.x     Document Type: Article

References (21)

1. Christophers E,. Psoriasis-epidemiology and clinical spectrum. Clin Exp Dermatol. 2001; 26: 314-20.
2. García-Diez A, Foraster CF, Sebastián FV, et al,. What characterizes the severity of psoriasis? Results from an epidemiological study of over 3,300 patients in the Iberian region. Dermatology. 2008; 216: 137-5.
3. Gisondi P, Tessari A, Conti A, et al,. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol. 2007; 157: 68-73. (Pubitemid 46934281)
4. Mallbris L, Akre O, Granath F, et al,. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol. 2004; 19: 225-30. (Pubitemid 38461682)
5. Neimann AL, Shin DB, Wang X, et al,. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol. 2006; 55: 829-35. (Pubitemid 44556851)
6. Kimball AB, Wu Y,. Cardiovascular disease and classic cardiovascular risk factors in patients with psoriasis. Int J Dermatol. 2009; 48: 1147-56.
7. Henseler T, Christophers E,. Disease concomitance in psoriasis. J Am Acad Dermatol. 1995; 26: 159-61.
8. Binazzi M, Calandra P, Lisi P,. Statistical association between psoriasis and diabetes: further results. Arch Dermatol Res. 1975; 254: 43-8.
9. Shapiro J, Cohen AD, David M, et al,. The association between psoriasis, diabetes mellitus, and the atherosclerosis in Israel: a case-control study. J Am Acad Dermatol. 2007; 56: 629-34. (Pubitemid 46400186)
10. Cohen AD, Dreiher J, Saphiro Y, et al,. Psoriasis and diabetes: a population based cross-sectional study. J Eur Acad Dermatol Venereol. 2008; 22: 585-9. (Pubitemid 351541054)
11. Mallbris L, Ritchlin CT, Stahle M,. Metabolic disorders in patients with psoriasis and psoriatic arthritis. Curr Rheumatol Rep. 2006; 8: 355-63. (Pubitemid 44638828)
12. Qureshi AA, Choi HK, Setty AR, et al,. Psoriasis and the risk of diabetes and hypertension: a prospective study of US female nurses. Arch Dermatol. 2009; 145: 379-82.
13. Armesto S, Coto-Segura P, Galache-Osuna C, et al,. Psoriasis and Hypertension: a case-control study. J Eur Acad Dermatol Venereol. 2011; doi: 10.1111/j.1468-3083.2011.04108.x.
14. Natali A, Toschi E, Baldeweg S, et al,. Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes. Diabetes. 2006; 55: 1133-40. (Pubitemid 44100192)
15. Duncan BB, Schmidt MI, Pankow JS, et al,. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes. 2003; 52: 1799-805. (Pubitemid 36792473)
16. Prey S, Paul C, Bronsard V, et al,. cardiovascular risk factors in patients with plaque psoriasis: a systematic review of epidemiological studies. J Eur Acad Dermatol Venereol. 2010; 24: 23-30.
17. Gelfand JM, Neimann AL, Shin DB, et al,. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006; 296: 1734-41.
18. Boehncke S, Thaci D, Beschmann H, et al,. Psoriasis patients show signs of insulin resistance. Br J Dermatol. 2007; 157: 1249-51. (Pubitemid 350115673)
19. Garden JM, Freinkel RK,. Systemic absorption of topical steroids. Metabolic effects as an index of mild hypercortisolism. Arch Dermatol. 1986; 122: 1007-10. (Pubitemid 16053113)
20. Dehghan A, van Hoek M, Sjibrands EJ, et al,. Risk of type 2 diabetes attributable to C-reactive protein and other risk factors. Diabetes Care. 2007; 30: 2695-9. (Pubitemid 47547822)
21. Wolf N, Quaranta M, Prescott NJ, et al,. Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Chron disease. J Med Gen. 2008; 45: 114-16. (Pubitemid 351252875)